Eledon Pharmaceuticals (ELDN)
3.02
+0.09 (3.07%)
Upcoming Events
Latest Headlines
Eledon files IND for islet cell trial, eyes Phase 3 kidney study
September 3, 2026 7:01 AM - StreetInsider
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial
September 3, 2026 7:00 AM - StreetInsider
Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
August 13, 2026 4:41 PM - StreetInsider
Form 10-Q Eledon Pharmaceuticals, For: Jun 30
August 13, 2026 4:32 PM - SEC Filing
Form 8-K Eledon Pharmaceuticals, For: Aug 13
August 13, 2026 4:10 PM - SEC Filing
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 13, 2026 4:05 PM - StreetInsider
Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Gros David-Alexandre C
August 4, 2026 5:23 PM - SEC Filing
Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Perrin Steven
August 4, 2026 5:22 PM - SEC Filing
Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:17 AM - SEC Filing
Rodman & Renshaw Starts Eledon Pharamceuticals (ELDN) at Buy
July 21, 2026 6:31 AM - StreetInsider
NewcelX gets FDA feedback supporting NCEL-101 diabetes trial path
July 1, 2026 9:30 AM - StreetInsider
NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
July 1, 2026 9:30 AM - StreetInsider
Natera and Eledon partner on kidney transplant Phase 3 trial
June 25, 2026 7:00 AM - StreetInsider
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026 7:00 AM - BizWire
Form 8-K Eledon Pharmaceuticals, For: Jun 18
June 22, 2026 5:00 PM - SEC Filing
Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
June 22, 2026 4:41 PM - StreetInsider
Eledon Pharamceuticals (ELDN) Reiterated at Overweight by Cantor Fitzgerald
June 22, 2026 7:35 AM - StreetInsider
Eledon reports Phase 2 kidney transplant drug data at ATC
June 22, 2026 7:00 AM - StreetInsider
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared wit
June 22, 2026 7:00 AM - StreetInsider
Eledon reports insulin independence in all 12 type 1 diabetes patients
June 8, 2026 7:02 AM - StreetInsider
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
June 8, 2026 7:00 AM - StreetInsider
Full Article List
